• Je něco špatně v tomto záznamu ?

Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels

P. Kušnierová, D. Zeman, P. Hradílek, M. Čábal, O. Zapletalová,

. 2019 ; 33 (7) : e22948. [pub] 20190614

Jazyk angličtina Země Spojené státy americké

Typ dokumentu srovnávací studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20006258

Grantová podpora
FNOs/2017 Ministry of Health, Czech Republic

BACKGROUND: Neurofilaments are the major cytoskeletal components of neurons, and cell injury leads to their release into the surrounding area. The aim of this study was to compare the cerebrospinal fluid (CSF) and serum (S) concentrations of neurofilament light chains (NFLs) and phosphorylated neurofilament heavy chains (pNFHs). METHODS: Neurofilament concentrations were measured in CSF and S samples from 172 patients using three enzyme-linked immunosorbent assays. Excel, Stata version 13, MedCal version 17.9.7., and NCSS 2007 software were used for the statistical analysis. RESULTS: There was a statistically significant correlation between the concentrations of CSF NFL and CSF pNFH (rs  = 0.748; n = 89; P < 0.001), but Passing-Bablok regression showed systematic deviation between the values obtained using the two assays. This indicates that the assays were not interchangeable. CSF pNFH and S pNFH concentrations showed low correlation. The kappa statistic showed moderate conformity between CSF pNFH and CSF NFL concentrations (κ = 0.556). CONCLUSIONS: The CSF NFL and CSF pNFH assays gave clinically consistent results that reflected the degree of axonal damage, independent of any particular neurological diagnosis. The S pNFH assays had a lower predictive value due to the low correlation coefficient and the kappa index of the CSF pNFH method.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006258
003      
CZ-PrNML
005      
20200521091336.0
007      
ta
008      
200511s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/jcla.22948 $2 doi
035    __
$a (PubMed)31199010
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kušnierová, Pavlína $u Department of Clinical Biochemistry, Institute of Laboratory Diagnostics, University Hospital Ostrava, Ostrava, Czech Republic.
245    10
$a Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels / $c P. Kušnierová, D. Zeman, P. Hradílek, M. Čábal, O. Zapletalová,
520    9_
$a BACKGROUND: Neurofilaments are the major cytoskeletal components of neurons, and cell injury leads to their release into the surrounding area. The aim of this study was to compare the cerebrospinal fluid (CSF) and serum (S) concentrations of neurofilament light chains (NFLs) and phosphorylated neurofilament heavy chains (pNFHs). METHODS: Neurofilament concentrations were measured in CSF and S samples from 172 patients using three enzyme-linked immunosorbent assays. Excel, Stata version 13, MedCal version 17.9.7., and NCSS 2007 software were used for the statistical analysis. RESULTS: There was a statistically significant correlation between the concentrations of CSF NFL and CSF pNFH (rs  = 0.748; n = 89; P < 0.001), but Passing-Bablok regression showed systematic deviation between the values obtained using the two assays. This indicates that the assays were not interchangeable. CSF pNFH and S pNFH concentrations showed low correlation. The kappa statistic showed moderate conformity between CSF pNFH and CSF NFL concentrations (κ = 0.556). CONCLUSIONS: The CSF NFL and CSF pNFH assays gave clinically consistent results that reflected the degree of axonal damage, independent of any particular neurological diagnosis. The S pNFH assays had a lower predictive value due to the low correlation coefficient and the kappa index of the CSF pNFH method.
650    _2
$a analýza rozptylu $7 D000704
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a intermediární filamenta $x metabolismus $7 D007382
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nemoci nervového systému $x krev $x diagnóza $x metabolismus $7 D009422
650    _2
$a neurofilamentové proteiny $x krev $x mozkomíšní mok $x metabolismus $7 D016900
650    _2
$a regresní analýza $7 D012044
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Zeman, David $u Department of Clinical Biochemistry, Institute of Laboratory Diagnostics, University Hospital Ostrava, Ostrava, Czech Republic. Clinic of Neurology, University Hospital Ostrava, Ostrava, Czech Republic.
700    1_
$a Hradílek, Pavel $u Clinic of Neurology, University Hospital Ostrava, Ostrava, Czech Republic.
700    1_
$a Čábal, Martin $u Clinic of Neurology, University Hospital Ostrava, Ostrava, Czech Republic.
700    1_
$a Zapletalová, Olga $u Clinic of Neurology, University Hospital Ostrava, Ostrava, Czech Republic.
773    0_
$w MED00009990 $t Journal of clinical laboratory analysis $x 1098-2825 $g Roč. 33, č. 7 (2019), s. e22948
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31199010 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200521091333 $b ABA008
999    __
$a ok $b bmc $g 1525116 $s 1096314
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 33 $c 7 $d e22948 $e 20190614 $i 1098-2825 $m Journal of clinical laboratory analysis $n J Clin Lab Anal $x MED00009990
GRA    __
$a FNOs/2017 $p Ministry of Health, Czech Republic
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace